GTBP
GT Biopharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
—
GT Biopharma, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
—
5.21
+0.08 · +1.56%
post 5.21 0.00%
No reported quarters.
No open-interest data.
No filed income statement.
Bar = avg |move| to ±8% · tick = ±4.8% avg day · ×base = |move| ÷ ±4.8% · min 6 releases
| Quarter | Reported | EPS | Consensus |
|---|---|---|---|
| Q2 FY26 | — | -0.12 | — |
| Q1 FY26 | — | -0.11 | — |
| Q3 FY25 | — | 1.04 | — |
Source: filed financials
Expected move
No implied move.
No linked exposure.